In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis

Béatrice Benedetti; Marco Rovaris; Maria A. Rocca; Domenico Caputo; Mauro Zaffaroni; Ruggero Capra; Antonio Bertolotto; Vittorio Martinelli; Gıancarlo Comı; Massimo Filippi

doi:10.1177/1352458509103714

Back

In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis

Article 2009 en

Abstract

1 min read

The similar WBNAA concentrations seen in BMS and early RRMS patients fit with the notion that a non-disabling long-term evolution of MS may be due, at least in part, to non-progression of pathology. Such a condition seems to be independent from MRI-visible lesions burden.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis

Massimo Filippi

Article2000

MRI correlates of cognitive dysfunction in multiple sclerosis patients.

Marco Rovaris, Massimo Filippi

Article2009

MRI features of benign multiple sclerosis

Marco Rovaris, Frederik Barkhof, Massimiliano Calabrese, Nicola De Stefano, Franz Fazekas, David H. Miller, Xavier Montalbán, Chris H. Polman, Maria A. Rocca, Alan J. Thompson, Tarek Yousry, Massimo Filippi

Article2009

A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients

Béatrice Benedetti, Maria A. Rocca, Marco Rovaris, Domenico Caputo, Mauro Zaffaroni, Ruggero Capra, Antonio Bertolotto, V Martinelli, Giancarlo Comi, Massimo Filippi

Article2002

MR-based technology for in vivo detection, characterization, and quantification of pathology of relapsing-remitting multiple sclerosis.

Marco Rovaris, Massimo Filippi